| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 4239461 | Journal of Vascular and Interventional Radiology | 2009 | 7 Pages |
Abstract
Transarterial treatments can be considered safe in patients with Child class A and B cirrhosis when an adjusted dose of epirubicin is used according to body surface, severity of liver disease, and white blood cell count. Accurate patient selection and procedure-related factors may reduce the frequency of complications and help preserve liver function.
Related Topics
Health Sciences
Medicine and Dentistry
Radiology and Imaging
Authors
Giada MD, Roberto MD, Angelo MD, Giovanni Battista MD, Daniela MD, Volpes MD, Adele MD, Ioannis MD, Luigi MD, Domenico MsC, Bruno MD,